| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 128.473.431 $ | -7.447.296 $ | +5,6 % | 9 | 135.431.499 $ | +7.732.821 $ | +18,5 % | 8 | 127.698.678 $ | +11.736.547 $ | +28,1 % | 8 | ||||
| JAMES INVESTMENT RESEARCH, INC. | → 0 | 54.909.559 $ | +609.643 $ | +1,1 % | 1 | 54.299.916 $ | -4.953.151 $ | -8,4 % | 1 | 59.253.067 $ | +8.489.025 $ | +16,7 % | 1 | ||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 43.520.995 $ | -3.268.529 $ | -7,0 % | 1 | 46.789.524 $ | +6.503.067 $ | +16,1 % | 1 | 40.286.457 $ | +2.260.065 $ | +5,9 % | 1 | |
| COZAD ASSET MANAGEMENT INC | → 0 | 12.782.293 $ | -1.187.070 $ | -8,5 % | 1 | 13.969.363 $ | +2.557.386 $ | +22,4 % | 1 | 11.411.977 $ | +740.739 $ | +6,9 % | 1 | ||
| VANGUARD GROUP INC | → 0 | 3.951.447 $ | -1.700.820 $ | -30,1 % | 1 | 5.652.267 $ | +1.267.072 $ | +28,9 % | 1 | 4.385.195 $ | -1.782.467 $ | -28,9 % | 1 | ||
| PROSHARES TRUST | → 0 | 3.449.097 $ | -1.789.795 $ | -34,2 % | 1 | 5.238.892 $ | +2.544.879 $ | +94,5 % | 1 | 2.694.013 $ | +1.836.248 $ | +214,1 % | 1 | ||
| Apple Inc. | AAPL | → 0 | Neutral | 2.939.995 $ | -511.635 $ | -14,8 % | 1 | 3.451.630 $ | +182.766 $ | +5,6 % | 1 | 3.268.864 $ | +565.849 $ | +20,9 % | 1 |
| GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | GOF | → 0 | 2.847.608 $ | -250.608 $ | -8,1 % | 1 | 3.098.216 $ | -337.102 $ | -9,8 % | 1 | 3.435.318 $ | -114.443 $ | -3,2 % | 1 | |
| BERKSHIRE HATHAWAY INC | BRK-B | → 0 | Neutral | 2.823.787 $ | -107.904 $ | -3,7 % | 1 | 2.931.691 $ | -32.096 $ | -1,1 % | 1 | 2.963.787 $ | -258.469 $ | -8,0 % | 1 |
| Connect Biopharma Holdings Ltd | CNTB | → 0 | Neutral | 1.248.650 $ | +759.422 $ | +155,2 % | 1 | ||||||||
| 128.473.431 $ | -7.447.296 $ | +5,6 % | 9 | 135.431.499 $ | +7.732.821 $ | +18,5 % | 8 | 127.698.678 $ | +11.736.547 $ | +28,1 % | 8 | ||||